Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
rituximab (rituxan) (1 trial)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (Phase 4)
Granulomatosis with Polyangiitis (Phase 4)
Microscopic Polyangiitis (Phase 4)
Vasculitis (Phase 4)
Trials (1 total)
Trial APIs (1 total)